Impact Biomedical, Inc. (“IBIO”) currently is a holding company operating mainly through our majority owned subsidiary,Global BioLife, Inc., which was incorporated on April 14, 2017. Impact BioMedical Inc. is a Nevada corporation and was incorporated in October 2018. Our principal executive offices are located at 1400 Broadfield Blvd., Suite 130, Houston, Texas.
